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We originally cloned and identified murine Zizimin2 (Ziz2, Dock11) as a guanine nucleotide exchange factor (GEF)
for Cdc42 and demonstrated that it activated the formation of filopodia. Since its expression pattern is restricted in
immune tissues and Rho GTPases such as Cdc42 function in B cell development and immune responses, we expected
Ziz2 to also be associated with B cell development and immune responses. However, the function of Ziz2 has not yet
been fully examined in vivo. We also recently discovered that Ziz2 expression levels in immune tissues were reduced
with aging in the mouse, suggesting that its expression is also associated with the mechanisms of immuno-senescence.
To gain insights into the mechanisms underlying immuno-senescence, we generated Ziz2 knock out (KO) mice
and examined the functions of Ziz2 in B cell development and immune responses. We also obtained Zizimin3
(Ziz3; Dock10) KO mice and examined the functions of Ziz3.
The results revealed that Ziz2 KO mice had a higher percentage of early bone marrow B cells (Fraction A), but a
reduced fraction of marginal zone (MZ) B cells. In addition, an examination of B cell-specific Ziz2 KO mice revealed that
Ziz2 was intrinsically required for MZ B cell development, but not for mature follicular B cells. However, immune
responses against NP-CGG (T cell-dependent), TNP-LPS (T cell-independent, TI, type I), and TNP-Ficoll (TI, type II)
were not altered in KO mice. We finally demonstrated that CD1d-positive MZ B cell region outside CD169-positive
marginal metallophilic macrophages (MMM) was narrowed in Ziz2 KO mice. Furthermore, MMM morphology appeared
to be altered in Ziz2 KO mice.
In conclusion, we herein showed that Ziz2 was associated with early bone marrow B cell development, MZ B cell
formation, MZ B number/localization around MZ, and MMM morphology which may explain in part the mechanism
underlying immuno-senescence.
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We originally cloned and identified [1] murine Zizimin2
(Ziz2, Dock11) as a guanine nucleotide exchange factor
(GEF) for Cdc42, one of the major Rho GTPases, and
demonstrated that it activated the formation of filopodia
in HEK293T cells [2]. Since its expression pattern was
previously shown to be restricted in immune tissues
such as the spleen, thymus, and lymph nodes [1], we ex-
pected Ziz2 to be associated with immune responses
and/or lymphocyte development. Moreover, we recently* Correspondence: michan@ncgg.go.jp
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unless otherwise stated.discovered that Ziz2 expression levels in immune tissues
were reduced with aging in the mouse [3], suggesting
that its expression is associated with the mechanisms
responsible for immuno-senescence.
B cells (as well as other hematopoietic cells) are gener-
ated in bone marrow (BM) from hematopoietic stem cells.
BM B cells grow in BM and migrate into the splenic B cell
region. In this region, immature B cells grow into two
types of mature B cells; mature follicular B cells (“M”),
which accumulate inside follicles along with the CXCL13
gradient through CXCR5, and marginal zone (MZ) B cells
(“MZ B”), which stall around MZ through the S1PR1/3-
S1P and/or integrin signaling pathway [4]. Another B cell
population, so called B1a, is also generated in BM, but isl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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responsible for antibody production in acquired immunity,
whereas MZ B and B1a B cells are involved in the protec-
tion process against infectious diseases by bridging the time
lag between innate and acquired immune response. Aged
mice have been shown to have lower numbers of MZ B
cells and, thus, are more susceptible to infectious diseases
[5]. The mechanisms underlying the age-dependent decline
in MZ B cells includes reductions in MZ macrophages and
the altered positioning of sinus lining cells and marginal
metallophilic macrophages around MZ. Aging also causes
defects in BM B cell development [6].
Previous studies on Rho GTPases, such as Cdc42, RhoA,
and Rac2, clearly demonstrated that they functioned in B
cell development and immune responses by regulating B
cell proliferation, survival, and migration, respectively
[7-9]. Thus, we expected Ziz2 to also function in these
events through its GEF activity. However, the functions ofFigure 1 Absence of Zizimin proteins, but normal numbers of hemato
(B) Protein lysates (30 μg/lane) were loaded and designated antibodies we
all antibodies. Zizimin proteins were absent in KO mice (8 weeks old, male
hemolytic reaction (C-E) or flow cytometric analysis (F). No significant diffe
female) per group from three independent experiments (one mouse per gZiz2 have not yet been fully examined in vivo. To gain in-
sights into the mechanisms underlying immuno-
senescence, we generated Ziz2 knock out (KO) mice and
examined the functions of Ziz2 in B cell development and
immune responses. We also obtained Zizimin3 (Ziz3;
Dock10) KO mice and examined its functions.
In the present study, we demonstrated that Ziz2 was
associated with early BM B cell development, MZ B cell
formation and localization around MZ, and thymic CD4+
T cell formation, which may explain in part the mechan-
ism responsible for immuno-senescence.
Results and discussion
Generation of Ziz2 or Ziz3 KO mice
We successfully generated and maintained Ziz2 or Ziz3
KO mouse line. We confirmed the absence of the protein
product of either gene in the KO mouse by western blot-
ting (Figure 1A-B). Both KO mice were viable and fertile.poietic cells in KO mice. (A-B) Western blotting for Ziz2 (A) or Ziz3
re reacted with the membranes. Replicated membranes were used for
). (C-F) The numbers of hematopoietic cells were counted after the
rence was observed among the groups (C-F). Three mice (8 weeks old,
roup per experiment) were used. 2KO: Ziz2 KO. 3KO: Ziz3 KO.
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mice. Thus, these results indicated that Ziz2 or Ziz3
has no critical role in regulating viability, fertility, or
malformations in mice.
Flow cytometric analysis
We next analyzed B and T cell development in KO mice.
We initially counted cells from BM, the spleen, thymus,
or peritoneal cavity, and then stained them for the flow
cytometric analysis. We noted that the numbers of
viable (Trypan blue negative) cells were not affected by
the deletion of the Ziz2 or Ziz3 gene (Figure 1C-F). In
the flow cytometric analysis, each fraction in the develop-
mental course of B or T cells in BM, the spleen, thymus,
or peritoneal cavity was examined. We assessed fractions
“A” to “F” for BM B cells [10], as shown in Figure 2A and
C. B220mid CD5mid cells [11] were checked for B1a cells
from the peritoneal cavity (Figure 3E). T1 (Transition 1),
T2, M (mature follicular), and MZ B cell fractions [12]
were analyzed for splenic B cells (Figure 3A and C). CD4+
and CD8+ fractions were analyzed in total thymocytes
for thymic T cells (Figure 4A). Regarding splenic T
cells, CD4+ and CD8+ cell fractions were examined in
CD3+ splenocytes (Figure 4C). The results showed that
the percentage of fraction “A” in BM B cells was higher
in Ziz2 or Ziz3 KO mice than in wild type (WT) mice
(Figure 2A-B). This may be explained by the reductionFigure 2 Early bone marrow B cell development was altered in KO m
“A-C” in CD43+ B220+ BM cells. Fraction “A” (Germline Pro-B): CD24− BP1−. F
CD24+ BP1+. (B) The percentage of fraction “A” was increased in KO mice.
D-F in CD43− B220+ BM cells. Fraction “D” (Pre-B late): IgM− IgD−. Fraction “
B): IgM+ IgD+. (D) The percentage of fraction “F” was not altered in KO mice. 2
per group from three independent experiments (one mouse per group per eof immature B cell development as shown in the KO
mice for Cdc42, which is a target of Ziz2 and possibly
of Ziz3, because hematopoietic stem cell (HSC)-specific
Cdc42 KO was previously shown to result in a reduc-
tion of Pro/Pre/immature B cells [7]. On the other
hand, other fractions in BM B cells were not affected in
KO mice (Figure 2C-D), which was contrary to the
phenotype of Cdc42 KO mice [7]. These results indi-
cated that Ziz2 or Ziz3 assisted in BM B cell develop-
ment from fractions “A” to “B” possibly through Cdc42.
These results also suggested that Cdc42 activation
required not only Ziz2 or Ziz3, but also other GEFs for
their role in BM B cell proliferation because HSC-
specific Cdc42 KO was found to result in significant
reductions in all other fractions of BM B cells.
Although the percentage of B1a cells was not altered
in KO mice (Figure 3E-F), the percentage of MZ B cells
was reduced in Ziz2 KO mice, but not in Ziz3 KO
(Figure 3A-B). The percentage of fraction “M” in splenic
B cells was not affected in KO mice (Figure 3C-D). In
addition, B cell-specific Ziz2 KO resulted in a reduction
in the MZ B cell percentage, but not that of mature fol-
licular B cells (Figure 5A-D). These results indicated that
MZ B cells, but not mature follicular B cells, intrinsically
required Ziz2 for proper development.
Regarding T cell development, the percentage of
thymic CD4+ T cells was increased in Ziz2 KO miceice. (A) Cell from BM were analyzed by flow cytometry for fractions
raction “B” (DJ-rearranged Pro-B): CD24+ BP1−. Fraction “C” (Pre-B early):
(C) Cells from BM were also analyzed by flow cytometry for fractions
E” (Newly-formed B): IgM+ IgD−. Fraction “F” (Follicular-type recirculating
KO: Ziz2 KO. 3KO: Ziz3 KO. *: P < 0.05 Three mice (8 weeks old, female)
xperiment) were used.
Figure 3 The percentage of marginal zone B cells was decreased in Ziz2 KO mice. (A) Splenocytes were analyzed by flow cytometry for T1
and MZ B cells in CD23− cells. T1: IgM+ CD21−. MZ: IgM+ CD21+. (B) The percentage of MZ B cells was decreased in Ziz2 KO mice. (C) Splenocytes
were analyzed by flow cytometry for T2 (Transition 2) and mature (M) B cells in CD23+ cells. T2: IgMhigh CD21+. M: IgMlow/middle CD21+.
(D) The percentage of “M” was not altered in KO mice. (E) Cells from the peritoneal cavity were analyzed by flow cytometry for B1a B cells in
B220+ cells. B1a: B220middle CD5middle. (F) The percentage of B1a cells was not altered among the groups. 2KO: Ziz2 KO. 3KO: Ziz3 KO. *: P < 0.05 Three
mice (8 weeks old, female) per group from three independent experiments (one mouse per group per experiment) were used.
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splenic CD8+ T cells was decreased in Ziz3 KO mice
(Figure 4C-D). These results suggested that Ziz2 sup-
pressed thymic CD4+ T cell formation, whereas Ziz3
assisted in splenic CD8+ T cell formation. Interestingly,
histological examination revealed that global architec-
tural features in thymus and spleen seemed to be indis-
tinguishable between WT and the KO mice (Additional
file 1: Figure S1). However, T cell development in thy-
mus or spleen may be altered in Ziz2 or Ziz3 KO mice,
respectively (Figure 4A-D). Thus, Ziz2 or Ziz3 may
affect T cell development, at least, in the cellular level.
For example, T cells are matured in thymus while mov-
ing from sub-capsular region to medulla through
contacting with other cortical epithelial cells, dendritic
cells, or macrophages. In this condition, Ziz2 may func-
tion upon contacting T cells with other cells and asdescribed above to form CD4+ T cells in thymus through
generating filopodiae. On the other hand, Ziz3 may
function upon invade from thymus into blood stream or
from blood stream into spleen because T cell develop-
ment in Ziz3 KO thymus was intact and a literature has
demonstrated its function in amoeboid invasion in mel-
anoma cells [13].
Taken together, the results of the flow cytometric ana-
lysis revealed that Ziz2 was associated with BM Pro B
cell, MZ B cell, and thymic CD4+ T cell formation. Ziz3
may also be associated with BM Pro B cell and splenic
CD8+ T cell formation. GTPases such as Cdc42 and
RhoA are known to be involved in B cell development;
however, it has not yet been established whether
GTPases are involved in T cell development in mice. We
here demonstrated that T cell development was altered
in Ziz2 or Ziz3 KO mice. Thus, Ziz2 or Ziz3 may
Figure 4 Thymic or splenic T cells were changed in Ziz2 or Ziz3 KO mice. (A) Thymocytes were analyzed by flow cytometry for double
negative (CD4− CD8−), double positive (CD4+ CD8+), CD4 single positive (CD4+ CD8−), or CD8 single positive (CD4− CD8+) T cells. (B) The
percentage of CD4(+) cells in thymocytes was increased in Ziz2 KO mice. (C) Splenocytes were analyzed by flow cytometry for CD4+ or CD8+ T
cells in CD3+ cells. (D) The percentage of CD8+ cells in CD3+ splenocytes was decreased in Ziz3 KO mice. 2KO: Ziz2 KO. 3KO: Ziz3 KO. *: P < 0.05
**: P < 0.01 Three mice (8 weeks old, female) per group from three independent experiments (one mouse per group per experiment) were used.
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through Cdc42 or other GTPases.
Immunization with T cell-dependent or T cell-
independent antigens
Since the percentage of B or T cells in the spleen or thy-
mus was altered in KO mice, we next examined immune
responses in these mice. NP-CGG was used for the T
cell-dependent (TD) antigen stimulation, and NP-specific
antibody concentrations in serum were measured by
ELISA. TNP-LPS (as type I) or TNP-Ficoll (as type II)
was used for the T cell-independent (TI) antigen stimu-
lation, and TNP-specific antibody titers (OD415/min)
were measured by ELISA. We expected altered immune
responses in KO mice, especially for TI antigens, be-
cause the number of MZ B cells, which are associated
with the production of antibodies against TI antigens,
was reduced in KO mice. However, no significant dif-
ference was observed in antibody titers between WT
and KO mice (Figure 6A-F; except for WT vs. Ziz3KO
on day 7 for NP-CGG, as shown in Figure 6A). Al-
though the immune response (IgM antibody titer) of
Ziz3 KO for NP-CGG was weaker than that of WT on
day 7, the response of Ziz3 KO mice against PBS ap-
peared to be similar. Thus, we assumed that thesignificant difference observed on day 7 may have been
caused by a technical deviation. Taken together, these
results indicated that Ziz2 or Ziz3 was not associated
with antibody production against TD and TI antigens.
GTPase KO mice, such as Cdc42 or Rac2, have been
reported to have reduced B cell numbers and weaker
immune responses [7,9]. Thus, these findings also indi-
cated that Ziz2 or Ziz3 may not be associated with
Cdc42 or Rac2 for TD or TI immune responses.
Histological examination of MZ B cells
To examine histological features in the Ziz2 or Ziz3 KO
spleen, especially for MZ B cell development, frozen
sections were stained with anti-B220 and anti-CD169
antibodies for B cells and marginal metallophilic macro-
phages (MMM), respectively. The MZ B cell region
(B220+ region outside of CD169+ cells) was significantly
narrower in KO mice than in WT mice (Figure 7A-B).
The reduction in the MZ B cell region in Ziz2 KO mice
was also confirmed by staining with another antibody
specific for CD1d, a marker of MZ B cells (Figure 8A-C).
These results indicated that Ziz2 or Ziz3 was associated
with MZ B cell localization around splenic MZ. S1PR1,
S1PR3, LFA1, VLA4, ICAM1, VCAM1, PYK2, LSC,
DOCK2, RAC2, and MARCO are known to be involved in
Figure 5 Reduction in marginal zone B cell percentage in B cell-specific Ziz2 KO mice. (A) Splenocytes were analyzed by flow cytometry
for T1 (Transition 1) and MZ B cells in CD23− cells. T1: IgM+ CD21−. MZ: IgM+ CD21+. (B) The percentage of MZ B cells was lower in CD19Cre/+;
Ziz2flox (Conditional KO) mice than in CD19Cre/+ (Control) mice. (C) Splenocytes were analyzed by flow cytometry for T2 and mature (M) B cells in
CD23+ cells. T2: IgMhigh CD21+. M: IgMlow/middle CD21+. (D) The percentage of “M” was not altered in KO mice. **: P < 0.01 Between seven and ten
mice (9–11 weeks old, male or female) per group from five independent experiments (from one to three mice per group per experiment) were used.
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rounding S1P (sphingosine-1-phosphate; a ligand for
S1PR1 and S1PR3) in blood or by MARCO expressed on
the cell surface of MZ macrophages (MZM), MZ B cells
stall in MZ due to an interfering powerful attraction
towards follicles through CXCR5-CXCL13 signaling. In
addition, integrin signaling-associated gene (e.g. Pyk2, Lsc,
Dock2, or Rac2) KO mice have a normal number of ma-
ture follicular B cells, but a low numbers of MZ B cells
and poor antibody responses to antigens [4,9,14-16]. In
these conditions, our results may suggest that Ziz2 func-
tions in MZ B cell retention around MZ through protrud-
ing filopodiae and utilizing integrin molecules by
activation of S1P/S1PR and/or MARCO signaling path-
way. In the present study, we also examined histologically
SIGN-R1+ MZMs and CD169+ MMMs that are important
surrounding partners for MZ B cells, for example, in TI
antigen presentation. The staining pattern indicated that
Ziz2 may be involved in forming dense MMM ring around
MZ because MMM ring around MZ was sparse in Ziz2KO mice (Figure 8A and Additional file 2: Figure S2A).
On the other hand, not only MMM number but also
MZM number seemed to be indistinguishable between
WT and Ziz2 KO mice (Additional file 2: Figure S2B).
MZM number is known to correlate with MZ B cell num-
ber [5]. In this study, however, MZ B cell number is
reduced in Ziz2 KO mice with no alteration in MZM
number. We reasoned that Ziz2 possibly has an import-
ant role to generate and localize MZ B cells around
MZ through connecting MZ B cells and MZMs by filo-
podiae [4]. Taken together, our results indicated that
Ziz2 was crucially involved in MZ B cell formation by
regulating MZ B cell localization around MZ and
MMM morphology, possibly through filopodiae by acti-
vation of S1P/S1PR, integrin, and/or MARCO signaling
pathway from MZM.
Proliferation assay
Since the percentage and localization of MZ B cells were
decreased in KO mice, we next analyzed the proliferative
Figure 6 Immune responses were not altered in KO mice. (A-B) Antigen(NP-CGG)-specific antibody titers [IgM in (A), IgG1 in (B)] in WT and
KO mice. Eight mice per group were used for the antigen-injected groups. (C-D) Antigen(TNP-LPS)-specific antibody titers [IgM in (C), IgG3 in
(D)]. Between eight and eleven mice per group were used for the antigen-injected groups. (E-F) Antigen(TNP-Ficoll)-specific antibody titers [IgM
in (E), IgG3 in (F)]. Between six and eight mice per group were used for the antigen-injected groups. Circles: WT, Triangles: Ziz2KO, Squares: Ziz3
KO, Open symbols: PBS-injected groups, Closed symbols: antigen-injected groups. **: P < 0.01.
Matsuda et al. Immunity & Ageing  (2015) 12:1 Page 7 of 12activity of MZ B cells in vitro. In the proliferation assay,
flow cytometry-sorted MZ B cells were incubated with
LPS and assessed by a colorimetric method (Figure 7C).
Contrary to our expectation, the results showed that
proliferative activity was not significantly different be-
tween WT and KO mice. These results suggested that
neither Ziz2 nor Ziz3 had any obvious function in the
proliferation of MZ B cells upon LPS stimulation.
Moreover, Ziz2 or Ziz3 may not be associated with
Cdc42 at least in B cell proliferation, as Cdc42 regu-
lates B cell proliferation.
Migration assay
We examined the migratory activity of splenic B cells
from KO mice in vitro towards BLC or SDF1 in order to
address the reduction in the number of MZ B cells in
KO mice. To assess migratory activity, all splenocytes
were loaded into the upper chamber of a transwell and
BLC or SDF1 was added to the lower chamber. Percent
migration was analyzed by counting the cell number of
each fraction of B cells in the input and lower chamberby flow cytometry. However, no significant difference
was observed in the migratory activities of WT and KO
(Figure 7D). Taken together, these data indicated that
Ziz2 was not associated with MZ B cell migration to-
wards BLC and SDF1. In other words, reduction of MZ
B cells in Ziz2 KO mice may be caused, at least, by alter-
ation of MZ B cell localization around MZ and/or
MMM morphology.
Conclusion
Regarding an association between MZ B cells and sus-
ceptibility against infectious diseases especially in aging
process, previous paper demonstrates that MZ B cell/
MZM number and localization of MMM/sinus lining
cells around MZ are changed upon aging in mice and it
can be one of the cause of age-associated higher sus-
ceptibility against infectious diseases [5,17]. MMM may
also activate CD1d-restricted invariant natural killer T
cells to promote rapid antibody response via extra-
follicular B cells [4]. In this study, MZ B cell reduction
(Figure 3A) and sparse MMM (Figures 7A and 8B, and
Figure 7 Marginal zone B cell regions were narrowed in Ziz2 KO mice. (A) Spleen sections were stained with anti-B220 (Red) and
anti-CD169 (Green) antibodies for the MZ B cell region (B220-positive region outside CD169-positive cells). All mice were 10 weeks old. Scale
bars: 100 μm. (B) MZ B cell regions were narrower in Ziz2 and Ziz3 KO mice than in wild type mice. (C) The proliferative activity of MZ B
cells in response to LPS was not altered in both KO mice. Three mice per group were used. Data from three independent experiments (one
mouse per group per experiment was used) were summarized. (D) The migratory activity of MZ B cells was analyzed using a transwell and
flow cytometry. Activity against BLC or SDF1 (SDF) was not altered in both KO mice. Four mice per group were used. Each plot indicates
data from one mouse. Data from four independent experiments (one mouse per group per experiment was used) were summarized.
2KO: Ziz2 KO. 3KO: Ziz3 KO. ***: P < 0.0001.
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MZM reduction (Additional file 2: Figure S2B), in Ziz2
KO mice. In addition, we observed that Ziz2 expression
level is decreased along with aging in splenic B cells
(reducing tendency was also observed in DC and T
cells, but not NK cells) (Additional file 3: Figure S3).
Thus, it is warranted in the future to test if the expres-
sion level of Ziz2 in MZ B cells / MMM reduces with
aging, possibly causing MZ B cell number decline and
morphological change of MMM. Nevertheless, Ziz2 KO
mice did not show any significant difference in rela-
tively early phase (from day 7 to 14) of immune
response against TD or TI antigens as compared to
WT mice (Figure 6). From this point of view, we could
not conclude that Ziz2 is associated with the immune
responses (also with the susceptibility against infectious
diseases). However, because MZ is also important for
long-lived memory B cell accommodation for T-cell
dependent antigens [17] which is generated in rela-
tively late phase (from day 28 to 35) of the immuneresponse , we are now focusing on the Ziz2 function in
memory B cell formation.
Regarding functional similarity between Ziz2 and Ziz3,
we initially expected that Ziz2 and Ziz3 have the same
function in vivo because of its structurally similarity. Al-
though we observed functional similarity in BM B cell
development, we also observed functional differences in
MZ B cell formation/localization, thymic CD4+ T cell
formation, and splenic CD8+ T cell formation. It is pos-
sible that Ziz2 or Ziz3 is expressed in different type of
cells in BM but same phenotype was observed in both
KO mice. It is also possible that upstream regulatory fac-
tor(s) may be different for Ziz2 and Ziz3, because IL4
up-regulates Ziz3 but not Ziz2 in human B cells [18].
For these issues, we are now trying to identify the
upstream transcriptional factor(s) by using reporter
assay with their putative promoter regions.
Taken together, we herein demonstrates that Ziz2 is
associated with early BM B cell development (from
Fractions “A” to “B”), MZ B cell formation and localization
Figure 8 Marginal zone B cell regions were narrowed in Ziz2 KO mice. (A-B) Splenic sections were stained with anti-CD1d (Magenta),
anti-CD169 (Green) (B), and anti-SIGN-R1(Blue) antibodies (A) Three mice per group were used. Between one and eight follicles per mouse
(per section) were captured. All mice were 10 weeks old. Scale bars: 100 μm. (C) The CD1d-positive region outside CD169-positive cells was
significantly narrower in Ziz2 KO mice than in the other groups. 2KO: Ziz2 KO. 3KO: Ziz3 KO. **: P < 0.01 ***: P < 0.0001 N = 7–15.
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other hand, Ziz3 was associated with early BM B cell
development (from Fraction “A” to “B”) and splenic
CD8+ T cell formation. These results also indicated
that the age-associated decline in Ziz2 may affect MZ
B cell formation/localization around MZ and MMM
morphology that will potentially affect susceptibility
for infectious diseases.
Methods
Generation of Ziz2 or Ziz3 KO mice
We generated Ziz2 KO mice using the Cre-loxP system.
Briefly, we inserted a targeting vector that had the Ziz2
exon1 sequence flanking two loxP sequences into
murine ES cells, transferred it into blastocysts, then
transplanted the blastocysts into the uterus of a pseudo-
pregnant foster mother. Chimera mice were mated with
WT mice to obtain flox mice. To obtain conventional
KO mice, flox mice were mated with CAG-Cre mice.Concerning Ziz3, we obtained frozen embryo from the
European Mouse Mutant Archive (EMMA) and trans-
ferred to generate Ziz3 KO mice. To generate B cell-
specific conditional KO mice, floxed Ziz2 mice were
mated with CD19 Cre/+ knock in mice. To confirm
genotypes by PCR, the following primers were used;
murine Ziz2 KO mice typing 5′-CGA TGT GTA TCC
GCA CTC AA-3′ (sense) and 5′-CAC AGC GGG TTT
CAC AGA G-3′ (antisense for floxed and WT allele) or
5′-GTC CAT TCC CAT GCT CTT GT-3′ (antisense for
deleted allele); murine Ziz3 KO mice typing 5′-TCA
ACC CAT TTC TGA CCT CC-3′ (sense) and 5′- GTT
CTG TGG CAC TGG AGG AT-3′ (antisense for
floxed and WT allele) or 5′-AGC GCA TCG CCT
TCT ATC GC-3′ (antisense for deleted allele);
CD19Cre 5′-AGA AGT CCT TAC TGG TGG AGG
TAG-3′ (sense) and 5′-AGC CCG GAC CGA CGA
TGA AG-3′ (antisense). In this study, 8–12 weeks old
mice were used.
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Western blotting was performed as described previously
[19]. Briefly, a protein lysate was prepared by homogen-
izing tissues with the IKA T10 basic hand mixer in RIPA
buffer (25 mM Tris–HCl pH7.6, 150 mM NaCl, 1 mM
EDTA, 1% NP-40, 1% Na-deoxycholate, 0.1% SDS, with
protease inhibitor; Roche, 04 693 132 001) and centrifu-
ging (13,000 g, 4°C, 20 minutes). Protein concentrations
were determined by the BCA assay (Thermo, 23227).
Thirty micrograms of the protein lysate was loaded onto
a 3-10% gradient gel (196–14621, Wako, Osaka, Japan)
and separated by electrophoresis at 20 mA (constant
current) per gel for 60 minutes. After semi-dry blotting
at 2 mA per cm2 for 80 minutes into Hybond-P (GE,
Amersham, RPN303F), the membrane was incubated
with 1% skimmed milk/PBST (0.1% Tween20/PBS) for
blocking while shaking at approximately 60–70 rpm in
a cold room overnight (around 16 hours). The first
antibody [For Zizimin1 (Dock9): Rabbit polyclonal,
NB500-265, Novus, 1:500; For Ziz2: Rat monoclonal, 214I9
[20], 1:100; For Ziz3: Rabbit polyclonal, NB100-60669,
Novus, 1:2000; For αTubulin: Mouse monoclonal,
T6074-200UL, Sigma, 1:2500] was diluted with the
blocking buffer and incubated with the membrane for
2 hours at room temperature while shaking horizontally
at 60–70 rpm. The appropriate secondary antibodies
conjugated with HRP (horseradish peroxidase) were in-
cubated with the membrane, as described for the first
antibody. Signals were detected by a chemiluminescent
method (Immobilon, WBKLS0500, Millipore).
Flow cytometric analysis
A flow cytometric analysis was performed as described
elsewhere [19]. Briefly, cells from bone marrow (BM),
the spleen, thymus, or peritoneal cavity were hemo-
lyzed with hemolytic buffer (150 mM NH4Cl, 10 mM
KHCO3, 0.1 mM EDTA, pH 7.3) and the viable cell
number was counted using the Trypan blue (0.1% by
PBS) exclusion method on a hemocytometer. The he-
molyzed cells were incubated with anti-CD16/32
(BioLegend, 101302, 1:100) for blocking on ice for
5 minutes. The primary antibodies were then incubated
with the cells on ice for 10 minutes. The primary anti-
bodies were as follows; anti-CD3-biotin (BD, 553060,
1:100), anti-CD4-APC (allophycocyanin) (BioLegend,
100515, 1:8000), anti-CD5-APC (BD, 550035, 1:200),
anti-CD8-FITC (fluorescein isothiocyanate) (BioLegend,
100705, 1:5000), anti-CD21-PE (phycoerythrin) (BioLe-
gend, 123409, 1:80), anti-CD23-biotin (BioLegend, 101603,
1:200), anti-CD24-biotin (eBioscience, 13-0242-81, 1:300),
anti-CD43-FITC (eBioscience, 11-0431-81, 1:1000), anti-
B220-APC (BioLegend, 103211, 1:160), anti-B220-PE
(BioLegend, 103207, 1:80), anti-BP1(Ly51)-PE (BioLegend,
108307, 1:80), anti-IgD-PE (BioLegend, 405705, 1:500),anti-IgM-PE Cy7 (BioLegend, 406513, 1:400). Before
being analyzed or sorted, the stained cells were re-
suspended in 7AAD (BioLegend, 420404, 1:60) diluted
in 1% BSA/PBS, and 7AAD-positive dead cells were
excluded from the experiments. The appropriate second-
ary reagents were applied [Streptavidin-APC (eBioscience,
17-4317-82, 1:1000), Streptavidin-PE Cy7 (BD, 557598,
1:1000 for BM cells or 1:9000 for T cells)]. An analysis
or sorting was performed with FACS AriaII (BD) or
FACS Cnato II (BD), respectively. The absolute num-
bers of cell populations from the peritoneal cavity
were divided by the volume (ml) of the medium (10%
FBS/RPMI 1640), which was collected from the peri-
toneal cavity.Histological examination
A histological examination was performed as described re-
cently [19]. In addition, anti B220-eFluor570 (eBioscience,
41-0452-80, 1:200) or CD1d-Pacific Blue (BioLegend,
123516, 1:50) was applied to the frozen sections with
CD169-FITC (AbD Serotec, MCA947F, 1:100) and
SIGNR1-APC (eBioscience, 17-2093-80, 1:20). Image J
(NIH, USA) was used to measure the MZ B cell region.
One marginal zone B cell region was chosen per figure.
The maximum width (along with the radial axis from
around the center point of white pulp) of the MZ B region
per figure was selected for data sampling. Between 3 and 4
mice per group were analyzed.Immunization and serum preparation
Regarding NP-CGG, 100 μg (per 100 μl of PBS per
mouse) of NP30-CGG (4-Hydroxy-3-nitrophenylacetyl
conjugated with chicken gamma globulin, Biosearch
Technologies, N-5055D-5) was incubated with aluminum
hydroxide/magnesium hydroxide (100 μl per mouse,
Imject Alum Adjuvant, Thermo, 77161) for 60 minutes at
approximately 20 rpm with a rotator at room temperature,
then 200 μl (100 μg of NP-CGG) per mouse of the antigen
solution was administered. Ten micrograms (per 200 μl of
PBS per mouse) of TNP40-Ficoll (2,4,6-Trinitrophenyl
conjugated with amino-ethyl-carboxy-methyl ficoll, Bio-
search Technologies, F-1300-10) was used for TNP-Ficoll.
Twenty micrograms (per 200 μl of PBS per mouse) of
TNP0.5-LPS (2,4,6, Trinitrophenyl conjugated with lipo-
polysaccharide, Biosearch Technologies, T-5065-1) was
used for TNP-LPS. All antigens (200 μl per mouse) were
injected into the peritoneal cavity.
Blood was collected from the tail vein at the desig-
nated time points. The collected blood in a 1.5 ml tube
was settled in a refrigerator overnight then centrifuged
at 1,000 g for 20 minutes at 4°C. The supernatant was
used as serum.
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An enzyme-linked immunosorbent assay (ELISA) was
performed as described previously [19]. NP-BSA (Bio-
search Technologies, N-5050 M-10, 10 μg/ml, 45 μl per
well) was used as an antigen for the NP-specific anti-
body. To assess the antibody titer, the velocity of optical
density (OD415/min, for TNP-specific antibody) or con-
centration (μg/ml, for NP-specific antibody) was calcu-
lated. To calculate the NP-specific antibody titer, a
standard curve was made with anti-NP antibodies
(N1G9 for IgG1 [21] or 267.7 μ for IgM [22]).
Proliferation assay
To assess the proliferative activity of MZ B cells from
WT or KO mice, MZ B cells (CD23− CD21high IgM+
splenocytes) were sorted by flow cytometry and incu-
bated (105 cells/well of a 96-well plate) for 3 days with
20 μg/ml of LPS (Sigma, L2630-25MG) diluted in 10%
FBS/RPMI1640. Proliferative activity was assessed by a
colorimetric assay (Wako, Dojindo, Cell Counting Kit 8,
347–07621). The incubation time was 6 hours at 37°C,
5% CO2. OD450 nm was used to detect signals. OD650
nm was used as a background signal.
Migration assay
The migration assay for MZ B cells was performed as
described previously [19], except for slight modifications
in the incubation time (4 hours) and recording condi-
tions [with FACS CantoII (BD), flow rate: High for
60 seconds].
Statistical analysis
Data are presented as the mean ± standard deviation,
except for Figure 6, in which only average values are
shown to improve the appearance of the data. Differ-
ences in the average values among groups were mainly
analyzed by a one-way ANOVA with Bonferroni’s mul-
tiple comparison test, except for Figure 6B-E, in which a
two-way ANOVA with Bonferroni’s multiple comparison
test was applied because an interaction between group
and time was not detected. P values less than 0.05 was
considered significant. These analyses were performed
on Prism 5.0 (Version 5.02, GraphPad Software, La
Jolla, CA, USA).
Additional files
Additional file 1: Figure S1. Hematoxylin and eosin (HE) staining of
spleen and thymus; Spleen or thymus from 8 weeks old male (WT/2KO)
or 14 weeks old female (3KO) mouse was excised and fixed in 10%
formalin, overnight in refrigerator. The tissues were embedded in paraffin
and sectioned into 2 μm then stained by HE. Representative figures from
one (3KO) to two (WT/2KO) mice were shown. Scale bars: 100 μm.
2KO: Ziz2 KO, 3KO: Ziz3 KO.Additional file 2: Figure S2. Marginal metallophilic macrophage (MMM)
and marginal zone macrophage (MZM) in Ziz2 KO mice (A) Splenic
sections from 9–10 weeks old female mice were stained with anti
CD169 (Green) antibody. From three to four sections per mouse (one
WT mouse and two KO mice were used) were stained and captured
multiple area for localization of CD169+ cells. Dense CD169+ cells that
are observed around MZ in WT sample (indicated by red line) seemed
sparse in the KO sample (indicated by red-separated lines). Scale bars:
10 μm (B) FACS analysis for MZM and MMM. MZM or MMM were analyzed
by staining splenocytes with anti SIGNR1 or anti CD169 antibody,
respectively. There is no significant difference between the groups.
WT: wild type. 2KO: Ziz2 KO. N = 9–18.
Additional file 3: Figure S3. Ziz2 expression levels in splenic B/DC/NK/T
cells from young (7–9 weeks old) or aged (2 years old) female mice.
Splenic B, DC (dendritic cell), NK (natural killer), or T cells were sorted as
B220+, CD11c+, NK1.1+, or CD3+ cells, respectively. Sorted cells were washed
by PBS then immersed by RNA later (Ambion). RNA was extracted from the
cells (that were pooled for three mice per group) by using QIAshredder and
RNeasy Micro Kit (Qiagen). Reverse transcription was performed by using
ReverTra Ace qPCR RT Master Mix with gDNA Remover (Toyobo). Five nano
gram per well of cDNA was mixed with Thunderbird qPCR Mix (Toyobo) and
TaqMan primer and prove (Assay ID: Mm01297557_m1 for Zizimin2 and
Mm99999915_g1 for GAPDH as internal control, Applied Biosystems) then
analyzed by PikoReal 96 Real-Time PCR System (Thermo scientific). Relative
expression level of Zizimin2 to GAPDH are shown (triplicate of one
representative experiment). The expression level of Zizimin2 in B cell
was reduced in aged mice. *: P < 0.05 ***: P < 0.0001 N = 3 (triplicate).
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